Methylene Blue Treatment of COVID-19
NCT04635605
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
SARS-CoV2
Interventions
DRUG:
Methylene Blue
DRUG:
Control Test
Sponsor
Fondazione Epatocentro Ticino